regulation protein secretion controlled aggregation endoplasmic reticulum 
system direct pharmacologic control protein secretion developed allow rapid pulsatile delivery therapeutic proteins protein engineered accumulated aggregates endoplasmic reticulum secretion stimulated synthetic small-molecule drug induces protein disaggregation rapid transient secretion growth hormone insulin achieved vitro vivo regulated pulse insulin secretion resulted transient correction serum glucose concentrations mouse model hyperglycemia approach may make gene therapy viable method delivery polypeptides require rapid regulated delivery 
